Ganodermycin, a novel inhibitor of CXCL10 expression from Ganoderma applanatum

被引:15
|
作者
Jung, Mathias [2 ]
Liermann, Johannes C. [3 ]
Opatz, Till [3 ]
Erkel, Gerhard [1 ]
机构
[1] Univ Kaiserslautern, Dept Biotechnol, D-67663 Kaiserslautern, Germany
[2] Inst Biotechnol & Drug Res IBWF, Kaiserslautern, Germany
[3] Johannes Gutenberg Univ Mainz, Inst Organ Chem, D-6500 Mainz, Germany
来源
JOURNAL OF ANTIBIOTICS | 2011年 / 64卷 / 10期
关键词
CXCL10; Ganoderma; inhibitor; new metabolite; INFLAMMATORY GENE-EXPRESSION; JUVABIONE; TARGETS; CELLS;
D O I
10.1038/ja.2011.64
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
CXCL10 (inducible protein-10) is a highly inducible chemoattractant, which contributes to the recruitment of inflammatory cells, such as macrophages and T-lymphocytes, and thereby has important roles in chronic inflammatory conditions. In a search for new inhibitors of CXCL10 expression in MonoMac6 cells, a novel compound, designated as Ganodermycin, was isolated from fermentations of the basidiomycete Ganoderma applanatum. The structure was determined by a combination of spectroscopic techniques. Ganodermycin inhibited the lipopolysaccharide (LPS)/interferon (IFN)-gamma-induced CXCL10 promoter activity in transiently transfected MonoMac6 cells in a dose-dependent manner with IC(50) values of 15-20 mu g ml(-1) (53-71 mu M). Ganodermycin also reduced LPS/IFN-gamma-induced CXCL10 protein synthesis and excretion. The Journal of Antibiotics (2011) 64, 683-686; doi:10.1038/ja.2011.64; published online 27 July 2011
引用
收藏
页码:683 / 686
页数:4
相关论文
共 50 条
  • [11] Hepatocyte growth factor reduces CXCL10 expression in keratinocytes
    Hisadome, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S155 - S155
  • [12] Hepatocyte growth factor reduces CXCL10 expression in keratinocytes
    Hisadome, Mitsuhiro
    Ohnishi, Tomokazu
    Kakimoto, Kyoko
    Kusuyama, Joji
    Bandow, Kenjiro
    Kanekura, Takuro
    Matsuguchi, Tetsuya
    FEBS LETTERS, 2016, 590 (20) : 3595 - 3605
  • [13] Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease
    Romagnani, P
    Rotondi, M
    Lazzeri, E
    Lasagni, L
    Francalanci, M
    Buonamano, A
    Milani, S
    Vitti, P
    Chiovato, L
    Tonacchera, M
    Bellastella, A
    Serio, M
    AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (01): : 195 - 206
  • [14] Protein expression and gene polymorphism of CXCL10 in patients with colorectal cancer
    Dimberg, Jan
    Skarstedt, Marita
    Lofgren, Sture
    Zar, Niklas
    Matussek, Andreas
    BIOMEDICAL REPORTS, 2014, 2 (03) : 340 - 343
  • [15] Increased CXCL10 expression in MS MSCs and monocytes is unaffected by AHSCT
    Bonechi, Elena
    Aldinucci, Alessandra
    Mazzanti, Benedetta
    di Gioia, Massimo
    Repice, Anna Maria
    Manuelli, Cinzia
    Saccardi, Riccardo
    Massacesi, Luca
    Ballerini, Clara
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2014, 1 (09): : 650 - 658
  • [16] Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis
    Rabquer, Bradley J.
    Tsou, Pei-Suen
    Hou, Yong
    Thirunavukkarasu, Eshwar
    Haines, G. Kenneth, III
    Impens, Ann J.
    Phillips, Kristine
    Kahaleh, Bashar
    Seibold, James R.
    Koch, Alisa E.
    ARTHRITIS RESEARCH & THERAPY, 2011, 13 (01)
  • [17] Longitudinal Expression of CXCL10 in Psoriasis Patients That Develop Psoriatic Arthritis
    Abji, Fatima
    Pollock, Remy
    Liang, Kun
    Chandran, Vinod
    Gladman, Dafna D.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [18] β-Funaltrexamine inhibits chemokine (CXCL10) expression in normal human astrocytes
    Davis, Randall L.
    Das, Subhas
    Buck, Daniel J.
    Stevens, Craig W.
    NEUROCHEMISTRY INTERNATIONAL, 2013, 62 (04) : 478 - 485
  • [19] CXCL10 Expression Is Elevated in Synovial Fluid of Psoriatic Arthritis Patients
    Muntyanu, Anastasiya
    Abji, Fatima
    Liang, Kun
    Chandran, Vinod
    Gladman, Dafna
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [20] CXCL10 expression as a marker of non-advanced endometrial cancer
    Dobroch, Jakub
    Sidorkiewicz, Iwona
    Niemira, Magdalena
    Knapp, Pawel
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A207 - A207